
2018: National Scientific Qualification as Associate Professor of General Microbiology (05/I2, BIO19).
2003: Visiting Scientist at Bauer Center for Genomic Research, Harvard University (Cambridge, MA, USA)
2003: PhD in Pharmacology and Toxicology (University of Florence)
1999-2000: Visiting PhD student at Harvard School of Public Health (Boston, MA, USA)
1995: M.Sc. in Biology (University of Florence)
2023–Present: Research Director (Dirigente di Ricerca), Institute of Biology and Agricultural Biotechnology (IBBA–CNR), Pisa Unit, Strategic Area “Food and Nutrition”2020-2022: Senior Staff Researcher at CNR-IBBA, Pisa, Italy
2016-2020: Staff Researcher at CNR-IBBA, Pisa, Italy
2015-2016: Research fellow at CNR-IBIMET, Florence, Italy
2011-2015: Staff Researcher, Dep. Food Quality and Nutrition, Fond. E.Mach, San Michele all’Adige (TN), Italy
2006-2011: Research fellow in Nutrigenomics, Dep. of Preclinical and Clinical Pharmacology, University of Florence Italy
2003-2006: Post-doctoral fellow, Dep. of Preclinical and Clinical Pharmacology, University of Florence, Italy
Research activities integrate functional genomics, toxicology, metagenomics, and metabolomics to investigate the role of diet and the gut microbiota in modulating intestinal inflammation and the risk of non-communicable diseases, including cancer, through a translational approach combining in vitro systems, in vivo animal models, and studies in patients and human volunteers.
The main research lines include: (i) analysis of the impact of diet on the composition and function of the gut microbiota in populations with different dietary patterns, including rural communities, and the contribution of fermented foods to healthy and sustainable dietary models; (ii) investigation of microbiota–host interactions in autoimmune, neurological, metabolic, and inflammatory diseases, aimed at identifying disease-associated microbial profiles and developing targeted dietary interventions; (iii) promotion of sustainable nutrition, including the reuse of food by-products, to support vulnerable populations; (iv) evaluation of the effects of dietary and probiotic interventions, including innovative dietary patterns such as the pescatarian diet, on gut microbiota health; and (v) contribution to food risk assessment and food safety activities in collaboration with national and international institutions, including EFSA.